PRODUCT DETAIL

Lapatinib Teva 250 mg filmom obalené tablety

Code

4424E

MA number

44/0215/23-S

Product Form:

tbl flm 140(2x70)x250 mg (blis.OPA/Al/PVC/Al-multibal.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EH	Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EH01	Lapatinib

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	28.09.2023
Validity:	28.09.2028
SPC:	SPC_Lapatinib Teva 250 mg filmom obalené tablety_09 2023.pdf
PIL:	PIL_Lapatinib Teva 250 mg filmom obalené tablety_09 2023.pdf
Safety feature	Yes
Data update:	05.10.2023